Edwards Lifesciences (EW) Treasury Shares (2009 - 2026)

Edwards Lifesciences has reported Treasury Shares for 18 years, with the latest figure at $7.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 16.48% year-over-year to $7.5 billion; the trailing twelve-month figure through Mar 2026 stood at $7.5 billion (up 16.48% YoY), and the FY2025 full-year result was $7.1 billion, up 14.52% from the prior year.
• Treasury Shares for Q1 2026 stood at $7.5 billion, up from $7.1 billion in the prior quarter.
• The five-year high for Treasury Shares was $83.0 million in Q1 2026, with the low at $1.1 million in Q3 2022.
• Average Treasury Shares over 5 years is $48.3 million, with a median of $49.4 million recorded in 2023.
• Year-over-year, Treasury Shares soared 71.46% in 2022 and advanced 14.37% in 2024.
• Tracing EW's Treasury Shares over 5 years: stood at $4.1 billion in 2022, then increased by 21.25% to $5.0 billion in 2023, then advanced by 23.24% to $6.2 billion in 2024, then gained by 14.52% to $7.1 billion in 2025, then rose by 5.95% to $7.5 billion in 2026.
• The last three Treasury Shares figures came in at $7.5 billion (Q1 2026), $7.1 billion (Q4 2025), and $7.0 billion (Q3 2025), per Business Quant data.

Peer Comparison